Sektorale Bewertungen Corcept Therapeutics Incorporated
Aktien
529882
US2183521028
CORT
Pharmazeutika
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
35,92 USD | +1,03 % | +4,78 % | +10,01 % |
29.07. | Transcript : Corcept Therapeutics Incorporated, Q2 2024 Earnings Call, Jul 29, 2024 | |
29.07. | Corcept Therapeutics Q2 Nettogewinn, Umsatzanstieg; Umsatzprognose für 2024 angehoben | MT |
Zu einer Liste hinzufügen 0 ausgewählt | KGV | Price to Book | PEG | EV / Sales | Marktkap. / EBITDA | Marktkap. / EBIT | Dividendenrendite (Y) | Kap. ($) | |
---|---|---|---|---|---|---|---|---|---|
32.08x | - | 1.8x | 4.74x | 22.78x | 22.81x | - | 3,71 Mrd. | ||
59.38x | 40,91 | 0.35x | 18.39x | 44.67x | 48.5x | +0,56% | 829 Mrd. | ||
39.21x | 27,48 | 1.78x | 13.66x | 27.81x | 30.86x | +1,28% | 583 Mrd. | ||
21.1x | 5,616 | -0.49x | 4.56x | 12.95x | 14.64x | +2,84% | 397 Mrd. | ||
37.87x | 41,13 | 0.43x | 7.17x | 15.49x | 16.07x | +3,20% | 344 Mrd. | ||
15.3x | 5,925 | 0x | 4.87x | 11.15x | 12.6x | +2,68% | 291 Mrd. | ||
16.04x | 5,950 | 0.94x | 3.81x | 9.97x | 11.07x | +3,66% | 255 Mrd. | ||
28.66x | 5,908 | 0.61x | 5.16x | 15.3x | 15.9x | +1,93% | 248 Mrd. | ||
21.31x | 5,210 | -0.87x | 4.91x | 12.44x | 13.11x | +3,29% | 232 Mrd. | ||
50.83x | 35,34 | -1.06x | 6.85x | 12x | 15.31x | +2,78% | 177 Mrd. | ||
21.78x | 1,917 | 0.08x | 3.72x | 10.18x | 12.21x | +5,61% | 168 Mrd. | ||
19.87x | 1,714 | 0.9x | 2.94x | 10.16x | 11.09x | +3,67% | 144 Mrd. | ||
300.67x | 5,119 | -3.2x | 4.26x | 11.7x | 15.9x | +3,80% | 101 Mrd. | ||
-24.63x | 5,238 | 0.16x | 2.93x | 25.55x | 30.07x | +4,92% | 98,51 Mrd. | ||
13.06x | 4,269 | 3.15x | 2.51x | 7.44x | 8.61x | +3,64% | 87,89 Mrd. | ||
29.28x | 5,781 | 2.47x | 8.79x | 18.5x | 19.82x | +1,34% | 75,39 Mrd. | ||
45.97x | 5,891 | 5.7x | 5x | 28.8x | 37.65x | +1,16% | 69,9 Mrd. | ||
58.97x | 0,9128 | -2.59x | 2.42x | 10.16x | 36.41x | +4,67% | 47,01 Mrd. | ||
24.93x | 2,116 | 0.63x | 3.81x | 15.09x | 16.94x | +1,63% | 46,8 Mrd. | ||
Durchschnitt | 42,72x | 11,47 | 0,57x | 5,82x | 16,95x | 20,50x | +2,93 % | 220,98 Mrd. | |
Gewichteter Durchschnitt nach Marktkapitalisierung | 40,04x | 19,42 | 0,45x | 8,77x | 21,56x | 24,15x | +2,39 % |
- Börse
- Aktien
- 529882 Aktie
- Sektor Corcept Therapeutics Incorporated
- Sektorale Bewertungen
MarketScreener is also available in this country: United States.
Switch edition